版本:
中国

BRIEF-Intellia Therapeutics, Crispr Therapeutics announce U.S. patent covering crispr/cas9 ribonucleoprotein complexes

April 26 Crispr Therapeutics AG

* Intellia Therapeutics and Crispr Therapeutics announce U.S. patent covering crispr/cas9 ribonucleoprotein complexes

* Crispr Therapeutics - United States patent and trademarks office is expected to issue a crispr/cas9 genome editing patent to Vilnius University

* Patent is expected to issue on May 2, 2017 as U.S. patent no. 9,637,739 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐